Skip to main content
Top
Published in: Trials 1/2022

Open Access 01-12-2022 | Commentary

Value and engagement: what can clinical trials learn from techniques used in not-for-profit marketing?

Authors: E. J. Mitchell, K. Sprange, S. Treweek, E. Nixon

Published in: Trials | Issue 1/2022

Login to get access

Abstract

Marketing is a core business function in commercial companies but is also frequently used by not-for-profit organisations. Marketing focuses on understanding what people value to make choices about engaging with a product or service: a concept also key to understanding why people may choose to engage with a clinical trial. Understanding the needs and values of stakeholders, whether they are participants, staff at recruiting sites or policy-makers, is critical for a clinical trial to be a success. As many trials fail to recruit and retain participants, perhaps it is time for us to consider approaches from other disciplines. Though clinical trial teams may consider evidence- and non-evidence-based recruitment and retention strategies, this is rarely done in a systematic, streamlined way and is often in response to challenges once the trial has started. In this short commentary, we argue the need for a formal marketing approach to be applied to clinical trials, from the outset, as a potential prevention to recruitment and retention problems.
Literature
2.
go back to reference Hannagan T. Marketing for the non-profit sector. Basingstoke: Macmillan Education UK; 1992. p. 208.CrossRef Hannagan T. Marketing for the non-profit sector. Basingstoke: Macmillan Education UK; 1992. p. 208.CrossRef
3.
go back to reference Wymer WK, Knowles PA, Gomes R. Nonprofit marketing: marketing management for charitable and nongovernmental organisations. London: Sage; 2006. Wymer WK, Knowles PA, Gomes R. Nonprofit marketing: marketing management for charitable and nongovernmental organisations. London: Sage; 2006.
4.
go back to reference Prahalad CK, Ramaswamy V. The co-creation connection. In: Strategy & Business; 2002. second quarter (27). Prahalad CK, Ramaswamy V. The co-creation connection. In: Strategy & Business; 2002. second quarter (27).
5.
go back to reference Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, et al. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials. 2020;21(1):694.CrossRef Witham MD, Anderson E, Carroll C, Dark PM, Down K, Hall AS, et al. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials. 2020;21(1):694.CrossRef
6.
go back to reference Treweek S, Banister K, Bower P, Cotton S, Devane D, Gardner HR, et al. Developing the INCLUDE Ethnicity Framework—a tool to help trialists design trials that better reflect the communities they serve. Trials. 2021;22(1):337.CrossRef Treweek S, Banister K, Bower P, Cotton S, Devane D, Gardner HR, et al. Developing the INCLUDE Ethnicity Framework—a tool to help trialists design trials that better reflect the communities they serve. Trials. 2021;22(1):337.CrossRef
7.
go back to reference Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007;11(48):iii, ix–105.CrossRef Campbell MK, Snowdon C, Francis D, Elbourne D, McDonald AM, Knight R, et al. Recruitment to randomised trials: strategies for trial enrollment and participation study. The STEPS study. Health Technol Assess. 2007;11(48):iii, ix–105.CrossRef
8.
go back to reference Gardner HR, Fraser C, MacLennan G, Treweek S. A protocol for a systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials. Syst Rev. 2016;5(1):131.CrossRef Gardner HR, Fraser C, MacLennan G, Treweek S. A protocol for a systematic review of non-randomised evaluations of strategies to improve participant recruitment to randomised controlled trials. Syst Rev. 2016;5(1):131.CrossRef
9.
go back to reference Francis D, Roberts I, Elbourne DR, Shakur H, Knight RC, Garcia J, et al. Marketing and clinical trials: a case study. Trials. 2007;8:37.CrossRef Francis D, Roberts I, Elbourne DR, Shakur H, Knight RC, Garcia J, et al. Marketing and clinical trials: a case study. Trials. 2007;8:37.CrossRef
10.
go back to reference Brunsdon D, Biesty L, Brocklehurst P, Brueton V, Devane D, Elliott J, et al. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials. 2019;20(1):593.CrossRef Brunsdon D, Biesty L, Brocklehurst P, Brueton V, Devane D, Elliott J, et al. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials. 2019;20(1):593.CrossRef
11.
go back to reference Gillies K, Brehaut J, Coffey T, Duncan EM, Francis JJ, Hey SP, et al. How can behavioural science help us design better trials? Trials. 2021;22(1):882.CrossRef Gillies K, Brehaut J, Coffey T, Duncan EM, Francis JJ, Hey SP, et al. How can behavioural science help us design better trials? Trials. 2021;22(1):882.CrossRef
12.
go back to reference Healy P, Galvin S, Williamson PR, Treweek S, Whiting C, Maeso B, et al. Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study. Trials. 2018;19(1):147.CrossRef Healy P, Galvin S, Williamson PR, Treweek S, Whiting C, Maeso B, et al. Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study. Trials. 2018;19(1):147.CrossRef
13.
go back to reference Houghton C, Dowling M, Meskell P, Hunter A, Gardner H, Conway A, et al. Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;10(10):Mr000045.PubMed Houghton C, Dowling M, Meskell P, Hunter A, Gardner H, Conway A, et al. Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;10(10):Mr000045.PubMed
14.
go back to reference Skea ZC, Newlands R, Gillies K. Exploring non-retention in clinical trials: a meta-ethnographic synthesis of studies reporting participant reasons for drop out. BMJ Open. 2019;9(6):e021959.CrossRef Skea ZC, Newlands R, Gillies K. Exploring non-retention in clinical trials: a meta-ethnographic synthesis of studies reporting participant reasons for drop out. BMJ Open. 2019;9(6):e021959.CrossRef
15.
go back to reference Leroux MK. The nonprofit marketing guide: high-impact, low-cost ways to build support for your good cause. San Francisco: Wiley; 2010. Leroux MK. The nonprofit marketing guide: high-impact, low-cost ways to build support for your good cause. San Francisco: Wiley; 2010.
16.
go back to reference Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth and happiness. Oxford: Integrated Environmental Assessment and Management; 2008. Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth and happiness. Oxford: Integrated Environmental Assessment and Management; 2008.
17.
go back to reference Lewis E. The growing pains of behavioural science. The Market Research Society (www.mrs.org.uk). 2021;35. Lewis E. The growing pains of behavioural science. The Market Research Society (www.​mrs.​org.​uk). 2021;35.
18.
go back to reference McDonald AM, Treweek S, Shakur H, Free C, Knight R, Speed C, et al. Using a business model approach and marketing techniques for recruitment to clinical trials. Trials. 2011;12:74.CrossRef McDonald AM, Treweek S, Shakur H, Free C, Knight R, Speed C, et al. Using a business model approach and marketing techniques for recruitment to clinical trials. Trials. 2011;12:74.CrossRef
19.
go back to reference Whitham D, Turzanski J, Bradshaw L, Clarke M, Culliford L, Duley L, et al. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study. Trials. 2018;19(1):557.CrossRef Whitham D, Turzanski J, Bradshaw L, Clarke M, Culliford L, Duley L, et al. Development of a standardised set of metrics for monitoring site performance in multicentre randomised trials: a Delphi study. Trials. 2018;19(1):557.CrossRef
20.
go back to reference Altman DG. The scandal of poor medical research. BMJ. 1994;308(6924):283–4.CrossRef Altman DG. The scandal of poor medical research. BMJ. 1994;308(6924):283–4.CrossRef
21.
go back to reference Van Calster B, Wynants L, Riley RD, van Smeden M, Collins GS. Methodology over metrics: current scientific standards are a disservice to patients and society. J Clin Epidemiol. 2021;138:219-26. Van Calster B, Wynants L, Riley RD, van Smeden M, Collins GS. Methodology over metrics: current scientific standards are a disservice to patients and society. J Clin Epidemiol. 2021;138:219-26.
22.
go back to reference Wyke S, Hunt K, Gray C, Fenwick E, Bunn C, Donnan P, et al. Football Fans in Training (FFIT): a randomised controlled trial of a gender-sensitised weight loss and healthy living programme for men – end of study report. Public Health Res. 2015;3(2). Wyke S, Hunt K, Gray C, Fenwick E, Bunn C, Donnan P, et al. Football Fans in Training (FFIT): a randomised controlled trial of a gender-sensitised weight loss and healthy living programme for men – end of study report. Public Health Res. 2015;3(2).
23.
go back to reference Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79.CrossRef Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79.CrossRef
24.
go back to reference Thomas KS, et al. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES Trial. Health Technol Assess. 2017;21(16). Thomas KS, et al. Randomised controlled trial of silk therapeutic garments for the management of atopic eczema in children: the CLOTHES Trial. Health Technol Assess. 2017;21(16).
25.
go back to reference Chalmers JR, Haines RH, Bradshaw LE, Montgomery AA, Thomas KS, Brown SJ, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet. 2020;395(10228):962–72.CrossRef Chalmers JR, Haines RH, Bradshaw LE, Montgomery AA, Thomas KS, Brown SJ, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet. 2020;395(10228):962–72.CrossRef
26.
go back to reference Walker J, Fairley CK, Urban E, Chen MY, Bradshaw C, Walker SM, et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia. BMC Public Health. 2011;11(1):156.CrossRef Walker J, Fairley CK, Urban E, Chen MY, Bradshaw C, Walker SM, et al. Maximising retention in a longitudinal study of genital Chlamydia trachomatis among young women in Australia. BMC Public Health. 2011;11(1):156.CrossRef
Metadata
Title
Value and engagement: what can clinical trials learn from techniques used in not-for-profit marketing?
Authors
E. J. Mitchell
K. Sprange
S. Treweek
E. Nixon
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Trials / Issue 1/2022
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-022-06417-3

Other articles of this Issue 1/2022

Trials 1/2022 Go to the issue